Home Site Map
Search:      
 
 
  Overview
  Management
  Collaborations & Contractors
  Business Strategy
  Investors
Business Strategy

Obecure intends to validate the safety and therapeutic efficacy of Histalean® for mitigation of side effects due to antipsychotic drugs through Phase II clinical trials.

For more advanced clinical studies, the company intends to seek partnerships and collaborations with major pharmaceutical companies that have established capacity in commercialization.  


 

Print Version Print Version       Send to a friend Send to a friend